{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:34:12Z","timestamp":1789932852778,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2011099"],"award-info":[{"award-number":["2011099"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bcmd.2017.09.006","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T16:17:39Z","timestamp":1506010659000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia"],"prefix":"10.1016","volume":"69","author":[{"given":"Marianne E.","family":"Yee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton H.","family":"Joiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Eckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Guasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2017.09.006_bb0005","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2017.09.006_bb0015","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-115-8-614","article-title":"Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality","volume":"115","author":"Powars","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0020","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00467-010-1736-2","article-title":"Sickle cell nephropathy: challenging the conventional wisdom","volume":"26","author":"Becker","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0025","article-title":"Hemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease","volume":"312","author":"Eshbach","year":"2017","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03940415","article-title":"Kidney disease among patients with sickle cell disease, hemoglobin SS and SC","volume":"11","author":"Drawz","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2141.2010.08523.x","article-title":"The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial","volume":"152","author":"Wang","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajh.23365","article-title":"Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia","volume":"88","author":"Aygun","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0045","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2009-05-221333","article-title":"The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)","volume":"115","author":"Voskaridou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2017.09.006_bb0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0055","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1681\/ASN.2014111126","article-title":"Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease","volume":"27","author":"Bartolucci","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/ndt\/gft295","article-title":"Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease","volume":"29","author":"Laurin","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26665","article-title":"Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease","author":"Tehseen","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bcmd.2017.09.006_bb0070","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ajh.23762","article-title":"The glomerulopathy of sickle cell disease","volume":"89","author":"Ataga","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0075","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MD.0b013e3181ca59b6","article-title":"Glomerular lesions in patients with sickle cell disease","volume":"89","author":"Maigne","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcmd.2017.09.006_bb0085","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199204023261402","article-title":"Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme","volume":"326","author":"Falk","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/en.2008-0886","article-title":"Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk","volume":"150","author":"Hosojima","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcmd.2017.09.006_bb0095","first-page":"481520","article-title":"Mechanisms of glomerular albumin filtration and tubular reabsorption","volume":"2012","author":"Tojo","year":"2012","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9343(98)00056-4","article-title":"A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia","volume":"104","author":"Foucan","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009191.pub3","article-title":"Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease","author":"Sasongko","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.24810","article-title":"Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial","volume":"92","author":"Quinn","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0115","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.bcmd.2017.09.006_bb0135","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.1002\/ajh.24840","article-title":"Estimation of glomerular filtration rate using serum cystatin C and creatinine in adults with sickle cell anemia","volume":"92","author":"Yee","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0140","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ki.1996.109","article-title":"Early detection and the course of glomerular injury in patients with sickle cell anemia","volume":"49","author":"Guasch","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0145","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ki.1997.116","article-title":"Sickle cell anemia causes a distinct pattern of glomerular dysfunction","volume":"51","author":"Guasch","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0150","first-page":"F374","article-title":"Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans","volume":"249","author":"Deen","year":"1985","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-9120(79)80081-8","article-title":"Evaluation of the Beckman Creatinine Analyzer 2","volume":"12","author":"Cottrell","year":"1979","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0165","series-title":"Weighted False Discovery Rate Controlling Procedures for Clinical Trials","author":"Benjamini","year":"2016"},{"key":"10.1016\/j.bcmd.2017.09.006_bb0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.23945","article-title":"Evidence gaps in the management of sickle cell disease: A summary of needed research","volume":"90","author":"Savage","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bcmd.2014.07.018","article-title":"Cystatin C: a useful marker of glomerulopathy in sickle cell disease?","volume":"54","author":"Asnani","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069922","article-title":"Determining glomerular filtration rate in homozygous sickle cell disease: utility of serum creatinine based estimating equations","volume":"8","author":"Asnani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2017.09.006_bb0185","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI22562","article-title":"Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography","volume":"114","author":"Wartiovaara","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1291\/hypres.26.413","article-title":"Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats","volume":"26","author":"Tojo","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0195","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0002-9440(10)62318-8","article-title":"Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury","volume":"166","author":"Nath","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0200","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9440(10)64037-0","article-title":"Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease","volume":"158","author":"Nath","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2016.04.001","article-title":"Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach","author":"Fox","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.bcmd.2017.09.006_bb0210","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2016070711","article-title":"Long-term endothelin-A receptor antagonism provides robust renal protection in humanized sickle cell disease mice","author":"Kasztan","year":"2017","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979617303303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979617303303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:34:06Z","timestamp":1761050046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979617303303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":42,"alternative-id":["S1079979617303303"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.09.006","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Losartan therapy decreases albuminuria with stable glomerular filtration and permselectivity in sickle cell anemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2017.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}